InvestorsHub Logo
Followers 59
Posts 7368
Boards Moderated 0
Alias Born 10/20/2014

Re: CaptBeer post# 423532

Thursday, 04/25/2024 7:02:09 PM

Thursday, April 25, 2024 7:02:09 PM

Post# of 423957
I wonder if Roche, Merck, or Bayer would have any issues in getting Germany
to reimburse for Vazkepa? Seems the most important thing that AMRN could
use is a Eurocentric BP acquirer. Of course, Denner is well aware of that so
us long suffering shareholders will simply have to wait until Denner gets what
he wants for the company. Maybe if we can get share price down to a new
52 week low around the start of the share buybacks that would help. I would
be surprised if Sarissa does not pick up more shares before the share buyback
begins.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News